ITD-1

N/A

Report date: 2023/01/12 16:08:18

Base Information

Drug NameITD-1
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Embryonic stem cells therapy
Mechanisms of ActionTransforming growth factor beta inhibitors
TargetsTransforming growth factor beta
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesChemRegen IncSanford Burnham Prebys Medical Discovery InstituteHuman BioMolecular Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHuman BioMolecular Research InstituteChemRegen IncSanford Burnham Prebys Medical Discovery Institute
Active IndicationsN/A
Inactive IndicationsHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A